Influence of kidney function stages with risk for developing cardiovascular disease in patients with hypertension
Keywords:
kidney function, hypertension, cardiovascular riskAbstract
This predictive correlational research by analyzing secondary data that is already recorded in the statistical analysis program aims to examine predictors of the influence between three phases of kidney function stages and potential high risk of cardiovascular disease in patients with hypertension. Participates were 490 patients attending four subdistrict health promotion hospitals in Nakhon Si Thammarat. Framingham risk assessment algorithm was used to consider the kidney function stages by determining the renal filtration rate criterion. Binary logistic regression was used to examine the predictive model with an odds ratio and the confident interval at 95 percent
The results indicated that the risk of cardiovascular disease in hypertension patients with kidneys functions from stage 3, 2, and 1 were 60.3, 48.9,27.2 percent, respectively. Binary logistic regression analysis presented that the risk of developing cardio vascular disease in hypertension patients increased from baseline examination when adjusting the combined influence of risk factors, including diastolic pressure, body mass index, and waist circumference. Patients with renal function stage 2 having more than two times of high risk prevalence (AOR 2.69, 95% CI 1.71-4.22, p <0.001) and a quadruple rise in group of patients with renal function stage 3 (AOR 4.48, 95% CI 2.39-8.38, p <0.001) by comparing to patients with stage 1 kidney function.
This study showed that kidney function stages influences with risk for developing cardiovascular disease in patients with hypertension. Thus, nurses should establish awareness and health behaviors modification programs to prevent and control risk factors for cardiovascular disease and progression.
References
Malik AO, Sehgal S, Ahmed HH, Devabhaktuni S, Co E, Malik AA, et al. Cardiovascular aspects of patients with chronic kidney disease and end-stage renal disease; 2018: doi: 10.5772/intechopen.69294
Ritchie H, Roser M. "Causes of Death". Published online at OurWorldInData.org; 2018 [cited 2020 Jun 18]. Available from: 'https://ourworldindata.org/causes-of-death' [Online Resource]
Hajar R. Framingham contribution to cardiovascular disease. Heart Views. 2016;17(2):78-81. doi:10.4103/ 1995-705X.185130
Subbiah AK, Chhabra YK, Mahajan S. Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia. 2016; 8: 56-61. Doi: 10.1136/heartasia-2016-010809
Said S, Hernandez GT. The link between chronic kidney disease and cardiovascular disease. J Nephropathol. 2014;3(3):99‐104. doi:10.12860/ jnp.2014.19
Systolic Blood Pressure Intervention Trial Research Group; Wright JT Jr, Williamson JD, Welton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-16.
Maraj I, Makaryus JN, Ashkar A, McFarlane SI, Makaryus AN. Hypertension management in the high cardiovascular risk population. Int J Hypertens. 2013; 2013:382802. doi:10.1155/ 2013/382802
Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74(1):120‐31. doi:10.1053/j. ajkd.2018.12.044
Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019;79(4):365‐79. doi:10.1007/s40265-019-1064-1
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM /AGS/APhA/ASH /ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. J Am Coll Cardiol. 2018; 71(6): 1269-1324.
Anderson AH, Yang W, Townsend RR, Pan Q, Chertow GM, Kusek JW, et al. Chronic renal in-sufficiency cohort study investigators: time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. Ann Intern Med. 2015; 162: 258–65.
Barzilay JI, Davis BR, Pressel SL, Ghosh A, Rahman M, Einhorn PT, et al. The effects of eGFR change on CVD, renal, and mortality outcomes in a hypertensive cohort treated with 3 different antihypertensive medications. Am J Hypertens. 2018;31(5):609‐14. doi:10.1093/ ajh/hpx223
Mark PB. Strategies to manage cardiovascular risk in chronic kidney disease. Nephrol Dial Transplant. 2018 Jan 1;33(1):23-5. doi: 10.1093/ndt/gfx329.
Neuman B. The Neuman Systems Model (3rd ed.). Norwalk, CT: Appleton & Lange; 1995.
Koson N, Suwanno J. Predictors of risk level for developing cardiovascular disease in patient with hypertension. Thai Journal of Cardio-Thoracic Nursing. 2019; 30(2): 66-81. (in Thai).
Barba C, Cavalli-Sforza T, Cutter J, Darnton-Hill I, Deurenberg P, Deurenberg-Yap M, et al., for WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-63.
National Kidney F. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis. 2012;60(5):850-86. doi: 10.1053/j.ajkd.2012. 07.005.
García-Gil M, Parramon D, Comas-Cufí M, Martí R, Ponjoan A, Alves-Cabratosa L, et al. Role of renal function in cardiovascular risk assessment: a retrospective cohort study in a population with low incidence of coronary heart disease. Prev Med. 2016;89:200‐206. doi:10.1016/j.ypmed.2016.06.004
Santoro A, Mandreoli M. Chronic renal disease and risk of cardiovascular morbidity-mortality. Kidney Blood Press Res. 2014; 39:142-46. doi: 10.1159/000355789
Barzilay JI, Davis BR, Pressel SL, Ghosh A, Rahman M, Einhorn PT, Cushman WC, Whelton PK, Wright JT Jr. The Effects of eGFR Change on CVD, Renal, and mortality outcomes in a hypertensive cohort treated with 3 different antihypertensive medications. Am J Hypertens. 2018;31(5):609-614. doi: 10.1093/ajh/hpx223. PMID: 29360915; PMCID: PMC5905651.
Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med.2013;158:825–30.
Bunrod K. Factor association for changing stage in chronic kidney disease, Chaiya hospital, Surat-Thani. Medical Journal. 2019; 33(3): 367 – 78. (in Thai)
Vaes B, Beke E, Truyers C, Elli S, Buntinx F, Verbakel JY, et al. The correlation between blood pressure and kidney function decline in older people: a registry-based cohort study. BMJ Open. 2015;5:e007571. doi: 10.1136/bmjopen-2015-007571
He, Yuan MD; Li, Fan MD; Wang, Fei MD; Ma, Xu MS; Zhao, Xiaolan MD; Zeng, Qiang MD The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults, Medicine. 2016;95(25):p e3769 doi: 10.1097/MD.00000 00000003769
Srina J, Sirivongs D, Adisuk D, Rattanakanokchai S, Methakanjanasak N, Surit P, Theeranut A. Factors associated with rapid decline of renal function in patients with kidney disease: a retrospective cohort study. Journal of Nursing Science & Health. 2018; 41(3): 108 – 18. (in Thai)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Thai Journal of Cardio-Thoracic Nursing
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความนี้ยังไม่เคยตีพิมพ์หรืออยู่ในระหว่างส่งไปตีพิมพ์ในวารสารอื่น ๆ มาก่อน และกองบรรณาธิการขอสงวนสิทธิ์ในการตรวจทาน และแก้ไขต้นฉบับตามเกณฑ์ของวารสาร ในกรณีที่เรื่องของท่านได้ได้รับการตีพิมพ์ในวารสารฉบับนี้ถือว่าเป็น ลิขสิทธิ์ของวารสารพยาบาลโรคหัวใจและทรวงอก
